/uploadedImages/Main/Content/PromoBoxes/brain-image.png?n=6628
Impact of AD on the brain

Synapse loss is an interventional target in mild Alzheimer’s disease

/uploadedImages/Main/Content/PromoBoxes/bottle-image.png
The role of medical nutrition

Medical nutrition provides an opportunity to address nutritional deficiencies that may impact cognition

/uploadedImages/Main/Content/PromoBoxes/book-image.png
The Souvenaid® story

Souvenaid is a nutritional intervention for patients early in the AD spectrum that contains Fortasyn Connect

/uploadedImages/Main/Content/PromoBoxes/magnifier-image.png
Clinical evidence

Synapse loss is an interventional target in mild Alzheimer’s disease

/uploadedImages/Main/Content/Resources/modular-1.png

Souvenaid® patient call card

info
/uploadedImages/Main/Content/Resources/modular-2.png
icon

Sean Lever: The benefits of Souvenaid®

info
/uploadedImages/Main/Content/Resources/modular-3.png
icon

Dr Negi explains how to recommend Souvenaid®

info
/uploadedImages/Main/Content/Resources/Professional_photo.jpg?n=858

Dr Bernadette McGuinness: Mild cognitive impairment a clinical perspective

info

“Taken together, membrane-related pathology and synapse loss play a central role in the pathogenesis of AD, and consequently provide viable interventional targets.”

– van Wijk N, et al. 2014

Update- The meeting report from the 5th Annual New Horizons Conference, May 2017, is now available in the Resources section

Dr Bernadette McGuinness' article "Mild Cognitive Impairment a Clinical Perspective" can be found within the reports section in Resources.